Sera Prognostics, Inc.'s (NASDAQ:SERA) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 24% Over Last Week
12 Health Care Stocks Moving In Monday's After-Market Session
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Leverage Metabolomics Data to Better Understand the Molecular Mechanisms of Rheumatoid Arthritis
Express News | Sera Prognostics - Entered Into Sales Agreement Relating to Shares of Class a Common Stock Offered by Prospectus
Express News | Sera Prognostics - May Offer, Sell Shares of Class a Common Stock of up to $50 Mln From Time to Time